FATE vs IT · rev $13.6M vs P/E 16, rev $6.27B
Fate Therapeutics Inc (FATE) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported FATE revenue for 2024-12-31 was $13.6M. Net income was -$186.3M. Revenue was down 78.5% from 2023-12-31 to 2024-12-31. FATE currently screens at market cap $331.0M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
FATE currently screens at market cap $331.0M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the FATE and IT stock pages for the full models.
Not investment advice.